The presented structural model of the ApoE4-specific intermediate state may serve to elucidate the molecular mechanisms underlying the physiopathological functions of ApoE isoforms, and it can pave the way for the development of alternative pharmacological strategies in the treatment of Alzheimer’s disease. The gene discussed is APOE; the disease is Alzheimer disease.